HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Warns Gilchrist & Soames Following Massive Contamination Recall

This article was originally published in The Rose Sheet

Executive Summary

G&S, which manufactures personal-care products for hotels and spas worldwide, recalled more than 2 million potentially contaminated units of bath and body products last year, but its regulatory compliance issues are not behind it yet. In a March 16 warning letter, FDA cites the firm for inspection failings and product sample analyses that render its products adulterated under US cosmetics law.

Advertisement

Related Content

FDA: Cosmetic Warning Letters Carry Same Weight Regardless Of Issuing Office
FDA Warning Letter Depicts Personal-Care Regulation's Present, Possible Future
FDA Has Eye On 'Non-Traditional Preservative' Use, Updates Internal Guide
Gemdo Warning Letter Speaks Volumes About FDA Concerns, Industry Challenges
FDA Updates Its Microbiological Safety Webpage Amid Recall Flurry
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA

Topics

Advertisement
UsernamePublicRestriction

Register

RS019853

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel